Hyperprogressive disease in second-line

Date 12 April 2018
Event ELCC 2018 European Lung Cancer Congress
Session Second line in non-oncogene addiction
Topics Anti-Cancer Agents & Biologic Therapy
Lung and other Thoracic Tumours
Presenter Benjamin Besse
Authors B. Besse
  • Dept Of Cancer Medicine, Gustave Roussy Institut de Cancérologie, 94805 - Villejuif/FR